01875 TOT BIOPHARM-B
- 1.510
- -0.060-3.82%
TOT BIOPHARM-B News
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
TOT BIOPHARM-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
TOT BIOPHARM-B: DATE OF BOARD MEETING
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
TOT BIOPHARM-B: FIRST LETTER AND REPLY FORM - ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
TOT BIOPHARM-B: ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
TOT BIOPHARM-B: CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
TOT BIOPHARM-B: INTERIM REPORT 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
TOT BIOPHARM-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
TOT BIOPHARM-B: CHANGE OF DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
TOT BIOPHARM-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
TOT BIOPHARM-B: DATE OF BOARD MEETING
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Analysis
Price Target
No Data
